Trendy ‘targeted therapy’ working on ulcerative colitis treatment too
‘Targeting’ has been a trend in the new drug development market for the past several years. New drugs had been developed with a mechanism of affecting the entire body, but the new drug paradigm is now changing to affecting only on organs or tissues to treat.
Recently, another ‘targeted’ drug was...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.